Skip to main content
Top

Breast Cancer Research and Treatment

Issue 2/2006

Content (13 Articles)

Preclinical Study

Rab11a Differentially Modulates Epidermal Growth Factor-induced Proliferation and Motility in Immortal Breast Cells

Diane Palmieri, Amina Bouadis, Ruban Ronchetti, Maria J. Merino, Patricia S. Steeg

Clinical Trial

Advanced breast cancer: anti-progressive immunotherapy using a thermostable autologous hemoderivative

Eduardo Lasalvia-Prisco, Jesús Vázquez, Wilson Golomar, Joshemaria Larrañaga, Emilio Garcia-Giralt, Silvia Cucchi, Eduardo Lasalvia-Galante

Clinical Trial

Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival

L. Kostadima, G. Pentheroudakis, G. Fountzilas, M. Dimopoulos, D. Pectasides, H. Gogas, C. Christodoulou, E. Samantas, D. Bafaloukos, P. Arapantoni, H. Kalofonos, P. Papakostas, T. Economopoulos, A. Bamias, N. Pavlidis, U. Stropp, R. Wirtz, G. Hennig

Clinical Trial

Association of GSTP1 CpG Islands Hypermethylation with Poor Prognosis in Human Breast Cancers

Takashi Arai, Yasuo Miyoshi, Seung Jin Kim, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi

Clinical trial

Economic Analysis of Psychosocial Group Therapy in Women with Metastatic Breast Cancer

Julie Lemieux, Adam Topp, Heather Chappell, Marguerite Ennis, Pamela J. Goodwin

Epidemiology

Psychological Distress in U.S. Women Who Have Experienced False-Positive Mammograms

Ismail Jatoi, Kangmin Zhu, Mona Shah, William Lawrence

Epidemiology

Infertility, Ovulation Induction Treatments and the Incidence of Breast Cancer—a Historical Prospective Cohort of Israeli Women

L. Lerner-Geva, L. Keinan-Boker, T. Blumstein, V. Boyko, L. Olmar, S. Mashiach, J. Rabinovici, G. Potashnik, E. Lunenfeld, J. G. Schenker, A. Shushan, A. Fishman, I. Cohen, I. Vagman, B. Lunenfeld

Epidemiology

Genetic Polymorphisms of eNOS, Hormone Receptor Status, and Survival of Breast Cancer

Ji-Yeob Choi, Kyoung-Mu Lee, Dong-Young Noh, Sei-Hyun Ahn, Jong-Eun Lee, Wonshik Han, In-Jin Jang, Sang-Goo Shin, Keun-Young Yoo, Richard B Hayes, Daehee Kang

Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study

Catherine Buettner, Candyce H. Kroenke, Russell S. Phillips, Roger B. Davis, David M. Eisenberg, Michelle D. Holmes

Letter to the Editor

REporting recommendations for tumor MARKer prognostic studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Sheila E. Taube, Massimo Gion, Gary M. Clark

Letter to the Editor

New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK

Daniel F. Hayes, Stephen Ethier, Marc E. Lippman

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine